Actual Medicinal Product (AMP) Majoven XL 37.5mg capsules (Bristol Laboratories Ltd)

Stability Information

(Some stability information inherited from generic)

Stability
compatible logo Suitable for use in MCAs, although use is likely to be off-label. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
Notes
There are no stability notes available for this medicine.
Provenance

This recommendation is based on the products Efexor XL 37.5mg prolonged release capsules(Upjohn UK Limited) and venlafaxine 37.5mg prolonged release hard capsules (Genus Pharmaceuticals).

Generic
Venlafaxine
Formulation
Venlafaxine 37.5mg modified-release capsules
  • Venlafaxine
    • Venlafaxine 37.5mg modified-release capsules

      • Majoven XL 37.5mg capsules (Bristol Laboratories Ltd)